GA4 (398745346)

Health & Happiness Group: The 13th China Maternal and Child Health Development Conference builds a new era of maternal and child health

Health & Happiness Group: The 13th China Maternal and Child Health Development Conference builds a new era of maternal and child health


From February 24th to 26th, H&H Group, as a global leader in the high-end nutrition and health industry, responded to the “Outline for the Development of Chinese Women (2021-2030)” and ” China Children’s Development Outline (2021-2030) “, together with its high-end infant nutrition and health brand Biostime, participated in the 13th China Maternal and Child Health Development Conference and GDM (Standardized Management of Gestational Diabetes and Prenatal Nutrition Intervention) ) project expert seminar, together with many leaders and experts, expressed their views on protecting the nutrition and health of mothers and children, and promoted the high-quality development of China’s maternal and child health.

The 13th China Maternal and Child Health Care Development Conference: Scientific research creates differentiation and adapts to the new needs of maternal and child health development

Mothers and infants are the basics of society, and the cause of human nutrition and health requires tens of thousands of hard work. In order to promote the construction of a healthy China and implement the new needs of maternal and infant health after the adjustment of the new national birth policy, the 13th China Maternal and Child Health Development Conference It was grandly held in Foshan City, Guangdong Province on February 24-25. The conference has a total of 1 main forum and 13 sub-forums. Well-known experts in obstetrics, gynecology and pediatrics at home and abroad will discuss the latest research hotspots and frontier issues in the field of women and children. In-depth discussion of orientation.

Relying on 24 years of unremitting efforts in the exploration and research of infant nutrition, and the organic combination of research results and product innovation, H&H Group was awarded the “2022 Maternal and Child Industry Cooperation Award” at the conference, and the corporate social value was once again recognized by maternal and infant authority recognized. Biostime, its high-end infant nutrition and health brand, was also invited to set up a booth to showcase the latest scientific research results and maternal and infant nutrition products, including star ingredients Lactopontin LPN, HMO (human milk oligosaccharides) and probiotics.

Knowing that practicing public welfare is to convey hope, H&H Group has maintained close project cooperation with the China Maternal and Child Health Care Association for a long time. As early as April 2021, H&H Group and the China Maternal and Child Health Care Association launched the “Mother and Child Protector Action” ——Maternal and Infant Nutrition Thousand-Day Plan” project, and officially released the “Mother and Infant Health Care Course for 1,000 Days in Early Life”, jointly calling on people from all walks of life to do a good job in popularizing nutrition and health in the early 1,000 days of life, and seize the early window period of infants and young children , to protect the health of pregnant women, infants and young children.

GDM project expert seminar: Join hands with authoritative institutions to protect the early 1000 days of life

Also dedicated to paying attention to the nutritional health of mothers and infants in the first 1000 days of life is the project “Early Intervention, Protecting Mothers and Infants – Standardized Management of Gestational Diabetes and Nutritional Intervention During Pregnancy” (hereinafter referred to as the GDM project). With the theme of “Baby”, it aims to solve the problem of early detection, early intervention and early prevention of maternal and infant serious illness relief, enhance the health awareness of mothers and infants, reduce the hazards of major diseases, and improve the nutritional health of pregnant women, infants and young children. An integral part of infant and child health. The project was launched in Beijing in July 2022 by the China Maternal and Child Health Association, the China Red Cross Foundation Biostime Maternal and Infant Relief Fund, and the China Maternal and Child Health Association Pregnancy Diabetes Professional Committee. An expert group was established to discuss the implementation details of the project plan, which once caused It has attracted the attention and response of many experts and scholars across the country.

On February 26, the China Maternal and Child Health Association once again joined hands with the China Red Cross Foundation and Biostime Maternal and Child Relief Fund to hold a GDM (gestational diabetes and pregnancy nutrition intervention standardized management) project expert seminar.

Yu Xiaoqian, executive vice president and secretary-general of the China Maternal and Child Health Association, delivered a speech at the meeting, pointing out: “The project will increase the popularization of women’s health knowledge, guide women to establish scientific health concepts, learn health knowledge, and carry out nutrition and dietary guidance according to local conditions. , promote women to learn and master nutritional knowledge, eat a balanced diet, eat a dynamic balance, prevent and control malnutrition and obesity, promote prenatal and postnatal care, and benefit tens of millions of mothers and children, and tens of millions of families.”

Yu Xiaoqian, Executive Vice President and Secretary General of China Maternal and Child Health Association

Zhu Hui, Director of the Office of Biostime Maternal and Infant Relief Fund of the China Red Cross Foundation, said: “I look forward to moving the threshold of assistance forward through innovative funding models, from ‘saving the sick’ to ‘saving the disease before’, and through supporting the establishment of The provincial-level demonstration center will carry out standardized construction and training, and promote the standardized management of maternal health during pregnancy, so that more mother-infant families will benefit from this, so as to realize the original intention of biostime to help mothers and infants and carry out mother-infant assistance.”

Zhu Hui, Director of the Office of Biostime Maternal and Child Relief Fund

There was a gathering of talents at the meeting site, and a total of more than 20 experts participated in this seminar. Among them are many important authoritative figures, including Chairman of the Professional Committee of Gestational Diabetes Associated with China Maternal and Child Health Association, Professor Yang Huixia, Director of Obstetrics and Gynecology Department of Peking University First Hospital.

Professor Yang Huixia, Director of Obstetrics and Gynecology, Peking University First Hospital

At the meeting, the letter of appointment was officially issued to the GDM project expert team, and the hospitals that had signed up for the project were evaluated, and it was determined that 30 national guidance centers would be established in batches within 3 years, and invited to formulate a GDM standardized management manual at the next meeting, gradually spreading to the whole country Promote the GDM standardized management model. As a project support unit, H&H Group assists in the overall implementation and promotion of the project. We look forward to popularizing scientific knowledge related to maternal and child health so that more pregnant women and families will pay attention to the importance of early life nutrition to the long-term health of mothers and children, and establish A healthy lifestyle can reduce the incidence of GDM and give birth to a healthy new life.

To give back to the society through public welfare, H&H Group has been on the road

As a project support unit, “making people healthier and happier” is the corporate mission of H&H Group, which has been fully integrated into H&H’s social responsibility management system. In the past 15 years, H&H Group has continuously expanded its public welfare territory, being a practitioner and advocate of social public welfare, and regards fulfilling corporate social responsibility as the key to sustainable development of enterprises.

Since 2003, H&H Group has established the Biostime Maternal and Infant Foundation and the H&H Foundation, two public welfare organizations, and has successively carried out the “Heart with You-Angel Journey” congenital heart disease screening and treatment campaign, the designated hospital project of love, the “breast milk More + Premature Infant Support” project, Biostime “Kiss Run” National Parent-child Charity Run, “Health Global Community Day” and other public welfare actions, as of the end of December 2022, the Group has donated more than 120 million yuan in donations The Biostime Maternal and Infant Relief Fund raised 67.79 million yuan, which has been used to help poor mothers and infants with a total amount of 60.11 million yuan. It has rescued 2,755 poor and severely ill mothers and children, and the recipients are all over mainland China.

Consolidate the power of public welfare and convey love and hope. H&H Group, which is deeply involved in the maternal and infant nutrition and health industry, takes the responsibility of protecting the health of mothers and infants and every family. Looking forward to the future, we will continue to uphold the principles of H&H Group’s Premium (high-end quality), Proven (scientific verification), and Aspirational (inspiring) Yearning, Pursuit of Excellence), Engaging (participation and interaction) PPAE business model, determined to become a global leader in high-end nutrition and health industry, boost the development of national health, and build a new era of maternal and child health with practical actions. (zero one)



Source link